Overview
While the initial evolution of meningococcal meningitis (MM) is well described, there are few data on the long-term evolution, beyond 1 year.
The objective of this research is to evaluate the sequelae of MM beyond 1 year in patients with a history of MM followed in Paris area, France. Most children with MM in France have been included in the MM register and are still being followed. Parents will be offered a detailed clinical evaluation of their child including: a clinical and neurological examination, a cognitive performance assessment, an auditory, speech and visual assessment and an evaluation of the child's progress at school.
Eligibility
Inclusion Criteria:
- Infants and children from 0 to 17 years old
- Having had meningitis or meningococcal purpura fulminans between 2010 and 2021
- Delay ≥ 1 year between the date of diagnosis of meningitis or purpura meningococcal fulminans and the date of inclusion in the study (signature of the informed consent)
- The holders of parental authority have read and understood the information letter and their express consent has been obtained
- Patient affiliated to a social security system (Social Security or Universal Medical Coverage)
Exclusion Criteria:
- refusal to participate